No Data
Express News | HC Wainwright & Co. Reiterates Buy on Regulus Therapeutics, Maintains $10 Price Target
H.C. Wainwright Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $10
H.C. Wainwright analyst Ram Selvaraju maintains $Regulus Therapeutics(RGLS.US)$ with a buy rating, and maintains the target price at $10.According to TipRanks data, the analyst has a success rate of 4
Buy Rating Affirmed for Regulus Therapeutics Amid Positive RGLS8429 Study Results
Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences
Express News | Canaccord Genuity Maintains Buy on Regulus Therapeutics, Raises Price Target to $28
Ball To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.JP Morgan c
Newbie93OP : it even penetrate through the daily 200ema
Newbie93OP : dead stock